Bencherif; Merouane

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bencherif; Merouane.The latest application filed is for "method for treating hyperhidrosis".

Company Profile

1.29.34

Bencherif; Merouane - Winston-Salem NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for treating hyperhidrosis with dexmecamylamine Grant 11,166,922 - Bencherif November 9, 2	2021-11-09
Method For Treating Hyperhidrosis App 20200360303 - BENCHERIF; Merouane	2020-11-19
Method for treating hyperhidrosis with dexmecamylamine Grant 10,507,190 - Bencherif Dec	2019-12-17
Method For Treating Hyperhidrosis App 20180369168 - Bencherif; Merouane	2018-12-27
Method for treating hyperhidrosis with dexmecamylamine Grant 10,080,726 - Bencherif September 25, 2	2018-09-25
Method For Treating Hyperhidrosis App 20170266132 - BENCHERIF; Merouane	2017-09-21
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide App 20170119746 - Bencherif; Merouane ; et al.	2017-05-04
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- robenzamide Grant 9,173,876 - Bencherif , et al. November 3, 2	2015-11-03
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide App 20150105421 - Bencherif; Merouane ; et al.	2015-04-16
(2s,3r)-n-2-3-pyridinylmethyl-1-azabicyclo 2.2.2 Oct-3-yl Benzofuran-2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20150045386 - Bencherif; Merouane ; et al.	2015-02-12
Method of treating bladder disorders Grant 8,901,177 - Bencherif , et al. December 2, 2	2014-12-02
Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobe- nzamide Grant 8,901,151 - Bencherif , et al. December 2, 2	2014-12-02
(2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2- -carboxamide novel salt forms, and methods of use thereof Grant 8,846,715 - Bencherif , et al. September 30, 2	2014-09-30
Treatment Wth Alphat Selective Ligands App 20140234270 - Bencherif; Merouane ; et al.	2014-08-21
Preparation And Therapeutic Applications Of (2s, 3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobe- Nzamide App 20140163065 - Bencherif; Merouane ; et al.	2014-06-12
(2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzyofurn-- 2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20140024673 - Bencherif; Merouane ; et al.	2014-01-23
Treatment Of Cognitive Dysfunction In Schizophrenia App 20140024638 - Bencherif; Merouane ; et al.	2014-01-23
Method Of Treating Bladder Disorders App 20130253067 - Bencherif; Merouane ; et al.	2013-09-26
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2- -carboxamide, novel salt forms, and methods of use thereof Grant 8,541,446 - Bencherif , et al. September 24, 2	2013-09-24
Arylvinylazacycloalkane Compounds For Constipation App 20130237550 - Toler; Steven M. ; et al.	2013-09-12
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluo- robenzamide Grant 8,476,296 - Bencherif , et al. July 2, 2	2013-07-02
Reversal Of L-dopa-induced Dyskinesia By Neuronal Nicotinic Receptor Ligands App 20120157477 - Jordan; Kristen G. ; et al.	2012-06-21
Treatment With Alpha7 Selective Ligands App 20110262407 - Bencherif; Merouane ; et al.	2011-10-27
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide App 20110257224 - Bencherif; Merouane ; et al.	2011-10-20
Treatment With Alpha 7-selective Ligands App 20110124678 - Bencherif; Merouane ; et al.	2011-05-26
Methods For Preventing The Development Of Retinopathy By The Oral Administration Of Nnr Ligands App 20110098312 - Bencherif; Merouane ; et al.	2011-04-28
Alpha 7 Nicotinic Agonists And Antipsychotics App 20110059947 - Bencherif; Merouane ; et al.	2011-03-10
Transdermal Administration Of (2S)-(4E)-N-Methyl-5-(3-(5-Isopropoxypyridin)yl)-4-Penten-2-Amine App 20100247617 - Bencherif; Merouane ; et al.	2010-09-30
Compounds Capable Of Activating Cholinergic Receptors App 20100121061 - Caldwell; William S. ; et al.	2010-05-13
Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs App 20100028447 - Letchworth; Sharon Rae ; et al.	2010-02-04
Method And Compositions For Treatment Of Cerebral Malaria App 20090239901 - Bencherif; Merouane	2009-09-24
Chimeric nicotinic receptor subunits Grant 7,550,293 - Bencherif , et al. June 23, 2	2009-06-23
Composition and pharmacology of novel alpha6-containing nicotinic acetylcholine receptors App 20090068642 - Bencherif; Merouane ; et al.	2009-03-12
2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzyofuran-- 2-carboxamide, Novel Salt Forms, And Methods Of Use Thereof App 20090048290 - Bencherif; Merouane ; et al.	2009-02-19
Pharmaceutical Compositions and Methods for Effecting Dopamine Release App 20070185086 - Bencherif; Merouane ; et al.	2007-08-09
Pharmaceutical compositions and methods for effecting dopamine release Grant 7,214,686 - Bencherif , et al. May 8, 2	2007-05-08
Compounds Capable of Activating Cholinergic Receptors App 20060293289 - Caldwell; William S. ; et al.	2006-12-28
Methods and compositions for treatment of central nervous system disorders App 20060160835 - Bencherif; Merouane ; et al.	2006-07-20
Methods and compositions for treatment of central nervous system disorders Grant 7,067,261 - Bencherif , et al. June 27, 2	2006-06-27
Compounds capable of activating cholinergic receptors Grant 7,045,538 - Caldwell , et al. May 16, 2	2006-05-16
Compounds capable of activating cholinergic receptors Grant 6,979,695 - Caldwell , et al. December 27, 2	2005-12-27
Methods and compositions relating to chimeric nicotinic receptor subunits App 20050255551 - Bencherif, Merouane ; et al.	2005-11-17
Compounds capable of activating cholinergic receptors App 20050148611 - Caldwell, William S. ; et al.	2005-07-07
Pharmaceutical compositions and methods for effecting dopamine release App 20040220214 - Bencherif, Merouane ; et al.	2004-11-04
Methods and compositions for treatment of central nervous system disorders App 20030158211 - Bencherif, Merouane ; et al.	2003-08-21
Compounds capable of activating cholinergic receptors App 20030125345 - Caldwell, William S. ; et al.	2003-07-03
Pharmaceutical compositions and methods for effecting dopamine release Grant 6,525,065 - Caldwell , et al. February 25, 2	2003-02-25
Pharmaceutical compositions for inhibition of cytokine production and secretion Grant 6,489,349 - Bencherif , et al. December 3, 2	2002-12-03
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders Grant 6,218,383 - Bencherif April 17, 2	2001-04-17
Pharmaceutical compositions for inhibition of cytokine production and secretion Grant 6,166,048 - Bencherif December 26, 2	2000-12-26
Methods for prevention and treatment of Tourette's syndrome and schizophrenia Grant 6,107,298 - Bencherif , et al. August 22, 2	2000-08-22
Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release Grant 5,952,339 - Bencherif , et al. September 14, 1	1999-09-14
Methods for prevention and treatment of attention deficit disorder Grant 5,885,998 - Bencherif , et al. March 23, 1	1999-03-23
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds Grant 5,861,423 - Caldwell , et al. January 19, 1	1999-01-19
Pharmaceutical compositions for prevention and treatment of central nervous system disorders Grant 5,824,692 - Lippiello , et al. October 20, 1	1998-10-20
Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow Grant 5,811,442 - Bencherif , et al. September 22, 1	1998-09-22
Pharmaceutical compositions for prevention and treatment of ulcerative colitis Grant 5,604,231 - Smith , et al. February 18, 1	1997-02-18
Pharmaceutical compositions for the treatment of central nervous system disorders Grant 5,583,140 - Bencherif , et al. December 10, 1	1996-12-10
Depolarizing skeletal muscle relaxants Grant 5,510,355 - Bencherif , et al. April 23, 1	1996-04-23

Company Registrations

SEC

0001295831

Bencherif Merouane

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.